XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (36,060) $ (68,801)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 3,537 1,980
Share-based compensation expense 44,434 45,999
Non-cash postcombination compensation expense 0 32,430
Non-cash operating leases expense 674 607
Amortization of premium (accretion of discount) on short-term investments (978) (975)
Other 181 209
Changes in operating assets and liabilities:    
Accounts receivable (4,271) 1,554
Settlements receivable (6,589) 6,768
Network incentives receivable (416) (16,702)
Prepaid expenses and other assets 538 7,203
Accounts payable 115 224
Revenue share payable 16,219 4,674
Accrued expenses and other liabilities (16,020) (24,907)
Operating lease liabilities (938) (809)
Net cash provided by (used in) operating activities 426 (10,546)
Cash flows from investing activities:    
Purchases of property and equipment (1,191) (577)
Capitalization of internal-use software (5,307) (3,032)
Business combination, net of cash acquired 0 (131,914)
Purchases of short-term investments 0 (70,807)
Maturities of short-term investments 40,000 108,000
Net cash provided by (used in) investing activities 33,502 (98,330)
Cash flows from financing activities:    
Proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options 49 1,016
Taxes paid related to net share settlement of restricted stock units (10,917) (3,746)
Repurchase of common stock (33,675) (21,826)
Net cash used in financing activities (44,543) (24,556)
Net decrease in cash, cash equivalents, and restricted cash (10,615) (133,432)
Cash, cash equivalents, and restricted cash- Beginning of period 989,472 1,191,646
Cash, cash equivalents, and restricted cash - End of period 978,857 1,058,214
Reconciliation of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 970,357 1,050,414
Restricted cash 8,500 7,800
Total cash, cash equivalents, and restricted cash 978,857 1,058,214
Supplemental disclosures of non-cash investing and financing activities:    
Purchase of property and equipment accrued and not yet paid 2,982 134
Share-based compensation capitalized to internal-use software 2,080 1,028
Repurchase of common stock, including excise tax, accrued and not yet paid $ 146 $ 232